Stocks and Investing Stocks and Investing
Mon, July 24, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Schmidt Maintained (WU) at Hold with Increased Target to $13 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brandon King Maintained (WTFC) at Strong Buy with Increased Target to $92 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Neal Dingmann Maintained (XOM) at Hold with Decreased Target to $110 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jon Tower Maintained (WING) at Hold with Decreased Target to $210 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Sykes Maintained (wgs) at Hold with Decreased Target to $8 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fotheringham Maintained (WRLD) at Sell with Increased Target to $59 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Hammond Initiated (WMS) at Buy and Held Target at $150 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vikram Purohit Reiterated (ASND) at Hold and Held Target at $109 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Coleman Downgraded (AA) to Hold on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Stephen Trent Maintained (AAL) at Hold with Decreased Target to $18 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Initiated (Z) at Hold and Held Target at $55 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Rishi Jaluria Downgraded (ZI) to Hold and Decreased Target to $28 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Nowak Initiated (ZG) at Hold and Held Target at $55 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Steven Alexopoulos Downgraded (ZION) to Hold on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Peter Winter Maintained (ZION) at Strong Buy with Increased Target to $42 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lawrence Keusch Upgraded (BDX) to Buy and Held Target at $305 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jason Bednar Maintained (BDX) at Buy with Increased Target to $305 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Joseph Pantginis Reiterated (BCDA) at Strong Buy and Held Target at $135 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Richard Shane Maintained (ACRE) at Hold with Increased Target to $10 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vijay Rakesh Maintained (AMAT) at Strong Buy with Increased Target to $152 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Alicia Reese Reiterated (AMC) at Sell and Held Target at $18 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vijay Rakesh Maintained (ALV) at Strong Buy with Increased Target to $106 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Luke Junk Maintained (ALV) at Hold with Increased Target to $106 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Alethia Young Reiterated (ALXO) at Buy and Held Target at $22 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Neal Dingmann Maintained (APA) at Strong Buy with Decreased Target to $56 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
John Freeman Maintained (APA) at Strong Buy with Decreased Target to $51 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Colin Langan Maintained (AN) at Hold with Decreased Target to $171 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Ward Reiterated (AN) at Strong Buy and Held Target at $200 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jonathan Elias Maintained (AN) at Strong Buy with Decreased Target to $179 on, Jul 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Chris Shibutani Upgraded (AMLX) to Strong Buy and Increased Target to $49 on, Jul 24th, 2023

Chris Shibutani Upgraded (AMLX) to Strong Buy and Increased Target to $49 on, Jul 24th, 2023


Published on 2024-10-28 05:04:15 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Upgraded "Amylyx Pharmaceuticals, Inc." (AMLX) to Strong Buy and Increased Target from $45 to $49 on, Jul 24th, 2023.

Chris has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris

  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Wednesday, May 31st, 2023
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $50 on, Monday, May 15th, 2023

Contributing Sources